Sunesis Pharmaceuticals Inc is a US-based biopharmaceutical company. It focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The product portfolio of the company includes Vosaroxin which is an anticancer quinolone derivative for the treatment of acute myeloid leukemia (AML). The company's other kinase inhibitor pipeline includes TAK-580, SNS-062, and SNS-229. Further, the firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The firm derives substantially the majority of revenue from license and collaboration agreements.

Related Companies

TickerCompanyChg %Mkt Cap

undefined Frequently Asked Questions

Q

How do I buy undefined (SNSS) stock?

A

You can purchase shares of (: ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are undefined's (SNSS) competitors?

A

There are no as such competitors for .

Q

What is the target price for undefined (SNSS) stock?

A

There is no analysis for

Q

Current Stock Price for undefined (SNSS)?

A

The stock price for (: ) is $ last updated Invalid Date.

Q

Does undefined (SNSS) pay a dividend?

A

There are no upcoming dividends for .

Q

When is undefined (undefined:SNSS) reporting earnings?

A

does not have any upcoming earnings scheduled.

Q

Is undefined (SNSS) going to split?

A

There is no upcoming split for .

Q

What sector and industry does undefined (SNSS) operate in?

A

is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the .